CORGENIX MEDICAL CORP/CO
company.status.inactiveCIK 1063665fmd_1YASSVBZSH8DAX2PPDD7M2F6FHManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard
Coverage: Jul 01, 2010 to Dec 31, 2014, 18 periods
| Line item | FY2011 | FY2012 | FY2013 | FY2014 |
|---|---|---|---|---|
| Total revenues | 8 | 9 | 10 | 11 |
| Cost of revenue | 4 | 5 | 6 | 6 |
| Gross profit | 4 | 4 | 5 | 5 |
| Research and development | 0 | 1 | 1 | 1 |
| Selling, general and administrative | 3 | 4 | 4 | 4 |
| Total operating expenses | 4 | 4 | 4 | 5 |
| Operating income | (0) | (0) | 0 | 0 |
| Interest expense | 0 | 0 | 0 | 0 |
| Interest and investment income | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | – | (0) | (0) | (0) |
| Income before taxes | – | – | 0 | 0 |
| Income tax expense | – | – | – | 0 |
| Net income from continuing operations | – | – | – | 0 |
| Net income | (0) | (1) | 0 | 0 |
| Net income to common shareholders | (0) | (1) | 0 | 0 |